Ospedale Centrale di Bolzano Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00355199
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Divisione di Ematologia - Ospedale Centrale di Bolzano - 39100 Bolzano Italy | Ospedale Centrale di Bolzano (Italy)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Non-Hodgkin (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6